Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)
China · Delayed Price · Currency is CNY 5.55
-0.25 (-4.31%)
Nov 6, 2026, 3:00 PM CST
SHA:600664 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3,266 | 3,437 | 3,634 | 3,060 | 2,433 | 1,592 |
Cash & Short-Term Investments | 3,266 | 3,437 | 3,634 | 3,060 | 2,433 | 1,592 |
Cash Growth | 19.18% | -5.44% | 18.75% | 25.76% | 52.85% | 77.49% |
Accounts Receivable | 5,491 | 4,748 | 4,985 | 4,961 | 4,818 | 4,749 |
Other Receivables | 133.52 | 129.57 | 130.8 | 146.47 | 178.51 | 85.86 |
Receivables | 5,625 | 4,878 | 5,116 | 5,107 | 4,997 | 4,835 |
Inventory | 2,035 | 2,061 | 1,891 | 1,924 | 1,804 | 2,064 |
Prepaid Expenses | - | 6.82 | 9.67 | 10.7 | 4.93 | - |
Other Current Assets | 399.65 | 270.93 | 327.8 | 293.61 | 320.05 | 242.45 |
Total Current Assets | 11,326 | 10,653 | 10,979 | 10,396 | 9,560 | 8,733 |
Property, Plant & Equipment | 2,273 | 2,338 | 2,385 | 2,468 | 2,641 | 2,835 |
Long-Term Investments | 31.06 | 31.06 | 33.49 | 38.42 | 37.62 | 39.32 |
Goodwill | 39.16 | 39.16 | 39.16 | 39.15 | 39.15 | 39.15 |
Other Intangible Assets | 414.44 | 411.55 | 408.4 | 451.14 | 444.21 | 480.78 |
Long-Term Deferred Tax Assets | 614.93 | 607.84 | 603.74 | 597.85 | 600.19 | 599.44 |
Long-Term Deferred Charges | 87.33 | 88.53 | 63.4 | 41.29 | 63.96 | 71.76 |
Other Long-Term Assets | 117.63 | 118.59 | 104.24 | 80.16 | 48.84 | 44.11 |
Total Assets | 14,903 | 14,288 | 14,616 | 14,112 | 13,435 | 12,842 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 4,068 | 4,032 | 4,039 | 3,951 | 3,510 | 3,482 |
Accrued Expenses | 518.04 | 602.44 | 618.37 | 597.07 | 668.02 | 628.3 |
Short-Term Debt | 859.74 | 1,041 | 1,554 | 1,658 | 1,933 | 2,078 |
Current Portion of Long-Term Debt | 142.08 | 105.47 | 104.76 | 104.04 | 103.64 | 102.92 |
Current Portion of Leases | - | 27.76 | 36.23 | 31.21 | 35.93 | 36.74 |
Current Income Taxes Payable | 132.49 | 43.91 | 57.21 | 80.1 | 98.29 | 85.17 |
Current Unearned Revenue | 178.33 | 130.74 | 311.61 | 282.45 | 235.87 | 119.73 |
Other Current Liabilities | 1,498 | 1,439 | 1,383 | 1,539 | 1,417 | 1,322 |
Total Current Liabilities | 7,396 | 7,423 | 8,105 | 8,243 | 8,002 | 7,855 |
Long-Term Debt | 31.55 | 31.48 | 31.7 | 32.63 | 33.19 | 34.09 |
Long-Term Leases | 29.51 | 30.16 | 35.32 | 31.08 | 43.68 | 61.61 |
Long-Term Unearned Revenue | 298.58 | 290.97 | 300.74 | 319.07 | 333.61 | 375.1 |
Long-Term Deferred Tax Liabilities | 9.74 | 7.59 | 5.73 | 6.91 | 6.29 | 1.68 |
Other Long-Term Liabilities | 42.78 | 42.78 | 47.98 | 56.64 | 69.7 | 94.7 |
Total Liabilities | 7,808 | 7,826 | 8,526 | 8,689 | 8,488 | 8,422 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 2,519 | 2,519 | 2,519 | 2,521 | 2,526 | 2,518 |
Additional Paid-In Capital | 670.27 | 663.33 | 684.11 | 685.32 | 688.6 | 675.43 |
Retained Earnings | 4,872 | 4,272 | 3,911 | 3,282 | 2,887 | 2,426 |
Treasury Stock | - | - | - | -3.98 | -13.01 | -15.53 |
Comprehensive Income & Other | -1,766 | -1,766 | -1,763 | -1,760 | -1,760 | -1,757 |
Total Common Equity | 6,296 | 5,688 | 5,350 | 4,724 | 4,328 | 3,847 |
Minority Interest | 798.97 | 774 | 739.49 | 698.75 | 618.87 | 573.25 |
Shareholders' Equity | 7,095 | 6,462 | 6,089 | 5,423 | 4,947 | 4,420 |
Total Liabilities & Equity | 14,903 | 14,288 | 14,616 | 14,112 | 13,435 | 12,842 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,063 | 1,236 | 1,762 | 1,857 | 2,149 | 2,313 |
Net Cash (Debt) | 2,203 | 2,201 | 1,872 | 1,203 | 284.1 | -720.94 |
Net Cash Growth | 47.42% | 17.58% | 55.56% | 323.57% | - | - |
Net Cash Per Share | 0.86 | 0.85 | 0.74 | 0.49 | 0.11 | -0.29 |
Filing Date Shares Outstanding | 2,519 | 2,519 | 2,519 | 2,521 | 2,526 | 2,518 |
Total Common Shares Outstanding | 2,519 | 2,519 | 2,519 | 2,521 | 2,526 | 2,518 |
Working Capital | 3,929 | 3,230 | 2,874 | 2,153 | 1,558 | 878.23 |
Book Value Per Share | 2.50 | 2.26 | 2.12 | 1.87 | 1.71 | 1.53 |
Tangible Book Value | 5,842 | 5,237 | 4,902 | 4,234 | 3,844 | 3,327 |
Tangible Book Value Per Share | 2.32 | 2.08 | 1.95 | 1.68 | 1.52 | 1.32 |
Buildings | - | 4,603 | 4,659 | 4,644 | 4,702 | 4,683 |
Machinery | - | 3,362 | 3,308 | 3,214 | 3,169 | 3,545 |
Construction In Progress | - | 65.56 | 74.73 | 69.12 | 66.22 | 164.92 |